Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Accounts Payables (2016 - 2025)

Historic Accounts Payables for AtriCure (ATRC) over the last 16 years, with Q3 2025 value amounting to $25.5 million.

  • AtriCure's Accounts Payables fell 1973.78% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.5 million, marking a year-over-year decrease of 1973.78%. This contributed to the annual value of $25.0 million for FY2024, which is 848.87% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Accounts Payables is $25.5 million, which was down 1973.78% from $25.7 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Accounts Payables ranged from a high of $31.7 million in Q3 2024 and a low of $15.5 million during Q1 2021
  • Over the past 5 years, AtriCure's median Accounts Payables value was $24.4 million (recorded in 2022), while the average stood at $23.4 million.
  • Per our database at Business Quant, AtriCure's Accounts Payables soared by 4601.92% in 2021 and then tumbled by 1973.78% in 2025.
  • Quarter analysis of 5 years shows AtriCure's Accounts Payables stood at $18.6 million in 2021, then increased by 7.0% to $19.9 million in 2022, then surged by 37.47% to $27.4 million in 2023, then fell by 8.49% to $25.0 million in 2024, then grew by 1.76% to $25.5 million in 2025.
  • Its Accounts Payables stands at $25.5 million for Q3 2025, versus $25.7 million for Q2 2025 and $25.2 million for Q1 2025.